ABOS · Company research

Acumen Pharmaceuticals, Inc. Common Stock (ABOS): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

16records availableHealthcare

Stock News & Events data

Database-backed records only

16 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
ABOS Should I Buy - Intellectia AIABOS Should I Buy Intellectia AIView source ↗Intellectia AIOct 3, 2026neutral00.6
Analysts’ Top Healthcare Picks: Acumen Pharmaceuticals (ABOS), High Tide (HITI) - The Globe and MailAnalysts’ Top Healthcare Picks: Acumen Pharmaceuticals (ABOS), High Tide (HITI) The Globe and MailView source ↗The Globe and MailSep 18, 2026neutral00.6
Acumen will meet investors online Sept. 16 - Stock TitanAcumen will meet investors online Sept. 16 Stock TitanView source ↗Stock TitanSep 10, 2026neutral00.6
An Alzheimer’s drug developer will join two live online events Sept. 9 and 10 - Stock TitanAn Alzheimer’s drug developer will join two live online events Sept. 9 and 10 Stock TitanView source ↗Stock TitanSep 2, 2026neutral00.6
$ABOS stock is up 13% today. Here's what we see in our data. - Quiver Quantitative$ABOS stock is up 13% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeAug 19, 2026neutral00.6
Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year? - Yahoo FinanceIs Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year? Yahoo FinanceView source ↗Yahoo FinanceJul 31, 2026neutral00.6
Price to earnings forward of Acumen Pharmaceuticals, Inc. – NASDAQ:ABOS - TradingViewPrice to earnings forward of Acumen Pharmaceuticals, Inc. – NASDAQ:ABOS TradingViewView source ↗TradingViewJul 27, 2026neutral00.6
All You Need to Know About Acumen Pharmaceuticals (ABOS) Rating Upgrade to Buy - Yahoo FinanceAll You Need to Know About Acumen Pharmaceuticals (ABOS) Rating Upgrade to Buy Yahoo FinanceView source ↗Yahoo FinanceJul 15, 2026neutral00.6
ABOS Forecast — Price Target — Prediction for 2027 - TradingViewABOS Forecast — Price Target — Prediction for 2027 TradingViewView source ↗TradingViewJun 25, 2026neutral00.6
Acumen bets on JCR’s brain-barrier tech for Alzheimer’s drug candidates - Stock TitanAcumen bets on JCR’s brain-barrier tech for Alzheimer’s drug candidates Stock TitanView source ↗Stock TitanJun 17, 2026neutral00.6
Acumen’s Late-2026 Sabirnetug Readout Is A Viable Bet (NASDAQ:ABOS) - Seeking AlphaAcumen’s Late-2026 Sabirnetug Readout Is A Viable Bet (NASDAQ:ABOS) Seeking AlphaView source ↗Seeking AlphaMay 20, 2026neutral00.6
Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year? - Yahoo FinanceIs Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year? Yahoo FinanceView source ↗Yahoo FinanceMar 30, 2026neutral00.6
Are Insider Tax-Related Sales Misaligned With Acumen Pharmaceuticals’ (ABOS) Alzheimer’s Trial Progress Narrative? - Simply Wall StreetAre Insider Tax-Related Sales Misaligned With Acumen Pharmaceuticals’ (ABOS) Alzheimer’s Trial Progress Narrative? Simply Wall StreetView source ↗Simply Wall StreetJan 27, 2026neutral00.6
Acumen Pharmaceuticals’ Share Volatility: Insight Into Recent Developments - StocksToTradeAcumen Pharmaceuticals’ Share Volatility: Insight Into Recent Developments StocksToTradeView source ↗StocksToTradeJan 26, 2026neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNMar 17, 2024neutral00.6
ABOS: Acumen Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas - StocktwitsABOS: Acumen Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas StocktwitsView source ↗StocktwitsJul 1, 2021neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.